CClinicalTrials.gg
CompletedNCT05236244Updated Oct 13, 2023

Motor Imagery in Healthy Individuals

An interventional study of İntervention group in Health, Subjective, sponsored by Bandırma Onyedi Eylül University. Completed at 1 site in Turkey. Open to participants aged 18 Years to 30 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2023-10-13.

Sponsored by Bandırma Onyedi Eylül University · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
30
Allocation
Randomized
Ages
18 Years to 30 Years
Sex
All
01

Study summary

The research will be the first to examine the relationship between mental fatigue induced by motor imagery and upper extremity performance. This study, it is aimed to examine whether the effects of mental fatigue created by motor imagery on upper extremity performance can be reduced by diaphragmatic breathing exercises.

02

Conditions studied

  • Health, Subjective

Browse trials for

Keywords

  • motor imagery
  • mental fatigue
  • diaphragmatic breathing exercises
03

In context

Mental Fatigue

154 studies on the registry are indexed under Mental Fatigue; 54 are open to participants now.

This study's enrollment of 30 is below the median of 47 across 124 interventional studies indexed under Mental Fatigue.

Browse Mental Fatigue studies →

Lead sponsor

Bandırma Onyedi Eylül University is the lead sponsor of 66 studies on the registry; 16 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 30 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

  • Right-handed dominance (it will be decided according to Edinburgh Hand Questionnaire Result)
  • Volunteer to participate in the study.
  • To be sedentary
  • Not having any problems that prevent breathing exercises
  • Be between the ages of 18-30

Exclusion criteria

Exclusion Criteria:

  • Have any mental or sensory problems in the past 6 months
  • Presence of acute infection or chronic disease of neurological, psychiatric, orthopedic, cardiological, rheumatological, etc.
  • Having had Covid-19
  • Having any respiratory disease (asthma, COPD, etc.)
  • Having any upper extremity injury and/or operation (trauma, surgery, fracture, etc.) in the -Last 6 months doing regular exercises (at least 30 minutes a day / 5 times a week for a total of at least 150 minutes)
  • Be on regular medication
  • Be smoking
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Participant, Outcomes assessor)
Enrollment
30 participants (actual)

Study arms

  • Experimental
    İntervention group

    Diaphragmatic breathing exercises: First Evaluation + (1 week break) + Motor imagery protocol + Second Evaluation + 8 weeks of diaphragmatic breathing exercises +Third Evaluation +(1 week interval) + Motor imagery protocol + Fourth Evaluation

    Other: İntervention group

  • No intervention
    Control Group

    First Evaluation + (1 week break) + Motor imagery protocol + Second Evaluation + 8 weeks break +Third Evaluation +(1 week interval) + Motor imagery protocol + Fourth Evaluation

Interventions

  • Otherİntervention group

    Diaphragmatic Breathing Exercises

06

What researchers measure

Primary outcomes

  1. 1-Isometric Elbow Flexion Force

    1-Isometric Elbow Flexion Force: The participant will try to move their hands towards their shoulder as forcefully as possible for 2-3 seconds with their upper arms at their sides, elbow bent at 90 degrees and forearm in supination.

    Time frame: 8 weeks

  2. 2-Handgrip strength

    2-Handgrip strength: Handgrip strength will be assessed using a Jamar hand dynamometer (Lafayette Instrument Company, USA).

    Time frame: 8 weeks

  3. 3-Upper extremity reaction test

    3-Upper extremity reaction test: It is planned to use a validated BlazePod sensor for upper extremity reaction time test

    Time frame: 8 weeks

  4. 4-Finger reaction test

    4-Finger reaction test: By placing the dominant hand index finger on the left button of a computer mouse, the participant will be asked to press the left button as soon as the traffic light pattern glows green on the screen.

    Time frame: 8 weeks

  5. 5-Hand performance test

    5-Hand performance test: A nine-hole peg test will be used.

    Time frame: 8 weeks

  6. 6-Position Sense

    6-Position Sense: The height of the laser track marker test target board can be adjusted according to the height of the person, and the zero point will be aligned for each patient's glenohumeral joint separately. A standardized coordinate system drawn on the target board will show the different angles of motion calculated using a formula.

    Time frame: 8 weeks

  7. 7-Tactile sense

    7-Tactile sense: The calibrated Semmes Weinstein monofilament test (North Coast Medical, USA) will be used to measure perceptual thresholds for cutaneous stimuli (Bell-Krotoski, Fess, Figarola, \& Hiltz, 1995; Dannenbaum, Michaelsen, Desrosiers, \& Levin, 2002).

    Time frame: 8 weeks

  8. 8-Two-point discrimination

    8-Two-point discrimination: The two-point discrimination test is the evaluation of the ability to detect stimuli applied from two different points at the same time.

    Time frame: 8 weeks

  9. 9-Upper extremity endurance test

    9-Upper extremity endurance test: After weighing the body weight, the weight to be held in the hand will be calculated as 2% of the body weight and if it is fractional, it will be rounded to the nearest 0.5 kg. The participant will hang the test arm out of the bed. Here he has to take the weight in his hand and raise it so that the "thumb faces up" and the arm is 90° horizontally. A metronome set to 60 Hz will then be used to standardize the test; in this way, participants will be instructed to raise their arms at the first beep, to keep the arm in 90 abduction during the next beep, and then to lower them to the starting position with the third beep. The test will be terminated as a result of fulfilling any of the following termination criteria (Moore, Uhl, \& Kibler, 2013).

    Time frame: 8 weeks

Secondary outcomes

  1. Mental Fatigue (VAS)

    VAS: In our study, mental fatigue level will be evaluated with VAS. VAS is a valid and reliable method for measuring the severity of fatigue and is a one-dimensional scale widely used in the clinic. In practice, patients are asked to choose the number that best describes the severity of fatigue they feel. Zero means not tired, 10 means very tired.

    Time frame: 8 weeks

07

Study locations

1 site
  • BandırmaOnyediEylulU
    Balıkesir, 10200, Turkey
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Oct 13, 2023, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05236244
Lead sponsor
Bandırma Onyedi Eylül University
Responsible party
Burçin Akçay (Assistant Professor, Bandırma Onyedi Eylül University) — Principal investigator
First posted
Feb 11, 2022
Start date
Apr 1, 2022
Primary completion
Jun 1, 2022
Completion
Mar 1, 2023
Last update
Oct 13, 2023

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Oct 2023. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion